{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,31]],"date-time":"2025-10-31T09:09:50Z","timestamp":1761901790004,"version":"build-2065373602"},"reference-count":10,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2020,11,1]],"date-time":"2020-11-01T00:00:00Z","timestamp":1604188800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,11,1]],"date-time":"2020-11-01T00:00:00Z","timestamp":1604188800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","msard-journal.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Multiple Sclerosis and Related Disorders"],"published-print":{"date-parts":[[2020,11]]},"DOI":"10.1016\/j.msard.2020.102465","type":"journal-article","created":{"date-parts":[[2020,8,31]],"date-time":"2020-08-31T11:36:42Z","timestamp":1598873802000},"page":"102465","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":3,"special_numbering":"C","title":["Occurrence of primary progressive multiple sclerosis in a patient with argyria: Causality or coincidence?"],"prefix":"10.1016","volume":"46","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-3086-6425","authenticated-orcid":false,"given":"Immanuel P.","family":"Seitz","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Markus C.","family":"Kowarik","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jennifer","family":"Sartor-Pfeiffer","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ulf","family":"Ziemann","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Helmut","family":"Wilhelm","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Karl Ulrich","family":"Bartz-Schmidt","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"3","key":"10.1016\/j.msard.2020.102465_bib0009","doi-asserted-by":"crossref","first-page":"495","DOI":"10.1007\/s12640-018-9977-0","article-title":"Prolonged exposure to silver nanoparticles results in oxidative stress in cerebral myelin","volume":"35","author":"D\u0105browska-Bouta","year":"2019","journal-title":"Neurotox. Res."},{"key":"10.1016\/j.msard.2020.102465_bib0010","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1016\/j.tox.2016.07.007","article-title":"Influence of a low dose of silver nanoparticles on cerebral myelin and behavior of adult rats","volume":"01","author":"D\u0105browska-Bouta","year":"2016","journal-title":"Toxicology"},{"issue":"3","key":"10.1016\/j.msard.2020.102465_bib0008","doi-asserted-by":"crossref","first-page":"416","DOI":"10.1016\/j.neuro.2012.04.008","article-title":"The similar neurotoxic effects of nanoparticulate and ionic silver in vivo and in vitro","volume":"33","author":"Hadrup","year":"2012","journal-title":"Neurotoxicology"},{"issue":"2","key":"10.1016\/j.msard.2020.102465_bib0003","doi-asserted-by":"crossref","first-page":"457","DOI":"10.1093\/toxsci\/kfs003","article-title":"Effects of silver nanoparticles on primary mixed neural cell cultures: uptake, oxidative stress and acute calcium responses","volume":"126","author":"Haase","year":"2012","journal-title":"Toxicol. Sci."},{"issue":"2","key":"10.1016\/j.msard.2020.102465_bib0006","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1080\/17435390.2018.1540728","article-title":"Silver nanoparticle-induced expression of proteins related to oxidative stress and neurodegeneration in an in vitro human blood-brain barrier model","volume":"13","author":"Khan","year":"2019","journal-title":"Nanotoxicology"},{"key":"10.1016\/j.msard.2020.102465_bib0002","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1016\/j.neuro.2014.11.002","article-title":"Synaptic degeneration in rat brain after prolonged oral exposure to silver nanoparticles","volume":"46","author":"Skalska","year":"2015","journal-title":"Neurotoxicology"},{"key":"10.1016\/j.msard.2020.102465_bib0004","doi-asserted-by":"crossref","first-page":"210","DOI":"10.1016\/j.neuro.2015.09.007","article-title":"Silver nanoparticles induced neurotoxicity through oxidative stress in rat cerebral astrocytes is distinct from the effects of silver ions","volume":"52","author":"Sun","year":"2016","journal-title":"Neurotoxicology"},{"issue":"1","key":"10.1016\/j.msard.2020.102465_bib0005","doi-asserted-by":"crossref","first-page":"160","DOI":"10.1093\/toxsci\/kfq244","article-title":"Silver nanoparticle induced blood-brain barrier inflammation and increased permeability in primary rat brain microvessel endothelial cells","volume":"118","author":"Trickler","year":"2010","journal-title":"Toxicol. Sci."},{"key":"10.1016\/j.msard.2020.102465_bib0001","first-page":"6105","article-title":"Silver nanoparticles induce tight junction disruption and astrocyte neurotoxicity in a rat blood-brain barrier primary triple coculture model","volume":"10","author":"Xu","year":"2015","journal-title":"Int. J. Nanomed."},{"key":"10.1016\/j.msard.2020.102465_bib0007","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1186\/1756-6606-6-29","article-title":"Silver nanoparticles (AgNPs) cause degeneration of cytoskeleton and disrupt synaptic machinery of cultured cortical neurons","volume":"6","author":"Xu","year":"2013","journal-title":"Mol Brain"}],"container-title":["Multiple Sclerosis and Related Disorders"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S221103482030540X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S221103482030540X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,31]],"date-time":"2025-10-31T08:57:31Z","timestamp":1761901051000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S221103482030540X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,11]]},"references-count":10,"alternative-id":["S221103482030540X"],"URL":"https:\/\/doi.org\/10.1016\/j.msard.2020.102465","relation":{},"ISSN":["2211-0348"],"issn-type":[{"type":"print","value":"2211-0348"}],"subject":[],"published":{"date-parts":[[2020,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Occurrence of primary progressive multiple sclerosis in a patient with argyria: Causality or coincidence?","name":"articletitle","label":"Article Title"},{"value":"Multiple Sclerosis and Related Disorders","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.msard.2020.102465","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"simple-article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2020 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"102465"}}